Intrinsic Value

Celyad Oncology SA (CYAD.BR)

0.84 €

+0.01 (+1.08%)
Enterprise Value -
Net Debt -27.39
Equity Value -
Shares Outstanding 31.47
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt